AC Immune boosts its preclinical Alzheimer's pipeline

14.January 2010 08:00 CET

English

  • In-licensing of promising memory enhancer ACI-518 from State University of Moscow to complement Alzheimer's disease drug pipeline
  • Proprietary Morphomer(TM) ACI-636 enters preclinical development